BDBM12254 1-{4-[2-({4-[(5-fluoro-2H-1,3-benzodioxol-4-yl)amino]-5-(propan-2-yloxy)quinazolin-7-yl}oxy)ethyl]piperazin-1-yl}ethan-1-one::7-[2-(4-Acetylpiperazin-1-yl)ethoxy]-N-(5-fluoro-1,3-benzodioxol--yl)-5-isopropoxyquinazolin-4-amine::AZD0530 analogue 32

SMILES CC(C)Oc1cc(OCCN2CCN(CC2)C(C)=O)cc2ncnc(Nc3c4OCOc4ccc3F)c12

InChI Key InChIKey=ODKPHHJCMRKOPX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 12254   

TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM12254(1-{4-[2-({4-[(5-fluoro-2H-1,3-benzodioxol-4-yl)ami...)
Affinity DataIC50:  6.50E+3nMAssay Description:An ELISA assay was used to determine the ability of inhibitor to inhibit VEGF-R RTK activity. The compounds were incubated with enzyme 20 min at room...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM12254(1-{4-[2-({4-[(5-fluoro-2H-1,3-benzodioxol-4-yl)ami...)
Affinity DataIC50:  20nMAssay Description:This assay determines the ability of test compounds to inhibit Src kinase activity that catalyzes the transfer of the terminal phosphate to the immob...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed